00007-9/assets/gr4.jpg)
(1–2) Changes in bladder capacity (1) and reflex volume (2) within the three groups. Group A: tolterodine + oxybutynin as treatment II; group B: trospium + tolterodine; group C: oxybutynin + trospium.
(1–2) Changes in bladder capacity (1) and reflex volume (2) within the three groups. Group A: tolterodine + oxybutynin as treatment II; group B: trospium + tolterodine; group C: oxybutynin + trospium.
Copyright © Elsevier B.V. All rights reserved
